96 related articles for article (PubMed ID: 18756880)
1. Long term results of age-related macular degeneration therapy with prednisolone acetate--special refer to peripheral visual field changes.
Vojniković B; Kovacević D; Njirić S; Coklo M
Coll Antropol; 2008 Jun; 32(2):351-3. PubMed ID: 18756880
[TBL] [Abstract][Full Text] [Related]
2. Prednisolone neuroprotective therapy in age-related macular degeneration.
Vojniković B; Spanjol J
Coll Antropol; 2007 Jan; 31 Suppl 1():69-70. PubMed ID: 17469755
[TBL] [Abstract][Full Text] [Related]
3. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.
Parisi V; Tedeschi M; Gallinaro G; Varano M; Saviano S; Piermarocchi S;
Ophthalmology; 2008 Feb; 115(2):324-333.e2. PubMed ID: 17716735
[TBL] [Abstract][Full Text] [Related]
4. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet.
Dagnelie G; Zorge IS; McDonald TM
Optometry; 2000 Mar; 71(3):147-64. PubMed ID: 10970259
[TBL] [Abstract][Full Text] [Related]
5. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H
Retina; 2009; 29(7):960-5. PubMed ID: 19491727
[TBL] [Abstract][Full Text] [Related]
6. Circular vection in patients with age-related macular degeneration.
Fushiki H; Takata S; Nagaki Y; Watanabe Y
J Vestib Res; 1999; 9(4):287-91. PubMed ID: 10472041
[TBL] [Abstract][Full Text] [Related]
7. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
Parravano M; Oddone F; Tedeschi M; Schiano Lomoriello D; Chiaravalloti A; Ripandelli G; Varano M
Retina; 2009 Mar; 29(3):329-34. PubMed ID: 19092732
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of the macula function by static perimetry, microperimetry and rarebit perimetry in patients suffering from dry age related macular degeneration].
Nowomiejska K; Oleszczuk A; Zubilewicz A; Krukowski J; Mańkowska A; Rejdak R; Zagórski Z
Klin Oczna; 2007; 109(4-6):131-4. PubMed ID: 17725269
[TBL] [Abstract][Full Text] [Related]
9. Sun exposure and visual field damage among children on the Adriatic Island Rab--possible initial risk factor in development of age-related macular degeneration.
Vojniković B; Micović V; Coklo M; Vojniković D
Coll Antropol; 2009 Sep; 33(3):747-9. PubMed ID: 19860099
[TBL] [Abstract][Full Text] [Related]
10. A novel high-resolution kinetic method for visual field mapping of scotoma in age-related macular degeneration.
Zur D; Ben Simon GJ; Loewenstein A; Alster Y; Moisseiev J; Ullman S
Ophthalmic Surg Lasers Imaging; 2004; 35(5):395-405. PubMed ID: 15497550
[TBL] [Abstract][Full Text] [Related]
11. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G
Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
[TBL] [Abstract][Full Text] [Related]
13. Age-related macular degeneration is not macular process only--peripheral retina is attacked too.
Vojniković B
Coll Antropol; 2007 Jan; 31 Suppl 1():3-5. PubMed ID: 17469740
[TBL] [Abstract][Full Text] [Related]
14. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
Lalwani GA; Rosenfeld PJ; Fung AE; Dubovy SR; Michels S; Feuer W; Davis JL; Flynn HW; Esquiabro M
Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
[TBL] [Abstract][Full Text] [Related]
15. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
16. [Personal experiences with conservative treatment of central retinal degeneration].
Pojda SM; Bandych-Biniszkiewiczowa D
Klin Oczna; 1992 Jan; 94(1):18-9. PubMed ID: 1635363
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
[TBL] [Abstract][Full Text] [Related]
18. Recovery of visual field defects: a large clinical observational study using vision restoration therapy.
Mueller I; Mast H; Sabel BA
Restor Neurol Neurosci; 2007; 25(5-6):563-72. PubMed ID: 18334773
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of retinal function after photodynamic therapy of subfoveal choroidal neovascularisation in patients with age-related macular degeneration].
Mozolewska-Piotrowska K; Lubiński W; Gosławski W; Karczewicz D; Szych Z
Ann Acad Med Stetin; 2007; 53 Suppl 1():16-21; discussion 21. PubMed ID: 19425475
[TBL] [Abstract][Full Text] [Related]
20. Reorganization of visual processing is related to eccentric viewing in patients with macular degeneration.
Schumacher EH; Jacko JA; Primo SA; Main KL; Moloney KP; Kinzel EN; Ginn J
Restor Neurol Neurosci; 2008; 26(4-5):391-402. PubMed ID: 18997314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
